Alexander Kohlmann

16.1k citations

181 papers · 7.5k indexed · 1 hit paper · h-index 44

Hematology top 0.1%
- Acute Myeloid Leukemia Research 115
- Chronic Myeloid Leukemia Treatments 27
Genetics top 0.5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 34
- Chronic Lymphocytic Leukemia Research 27
Cancer Research top 1%
- Cancer Genomics and Diagnostics 34
Oncology top 1%
Molecular Biology top 2%
- Gene expression and cancer classification 24
- Advanced biosensing and bioanalysis techniques 16
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 22

Co-authors: Torsten Haferlach Susanne Schnittger Wolfgang Kern Claudia Haferlach Martin Dugas Claudia Schoch Vera Grossmann Frank Dicker
Cited by: Hematology Genetics Cancer Research
Journals: Blood (82 papers)Leukemia (13 papers)Genes Chromosomes and Cancer (10 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Alexander Kohlmann

177 papers receiving 7.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Alexander Kohlmann

Since Specialization

Citations

This map shows the geographic impact of Alexander Kohlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Kohlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Kohlmann more than expected).

Fields of papers citing papers by Alexander Kohlmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Kohlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Kohlmann. The network helps show where Alexander Kohlmann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alexander Kohlmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alexander Kohlmann Line = papers co-authored together Alexander Kohlmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pan-Tumor Analytical Validation and Osimertinib Clinical Validation in EGFR Mutant Non–Small-Cell Lung Cancer, Supporting the First Next-Generation Sequencing Liquid Biopsy in Vitro Diagnostic Journal of Molecular Diagnostics ·Jhanelle E. Gray,Ji‐Youn Han,Lina María Díaz-Sarmiento,Xiangning Huang,Alexander Kohlmann,Rachel Hodge,Yuri Rukazenkov,Juliann Chmielecki,Carin R. Espenschied,Martina I. Lefterova,Yi‐Long Wu,Suresh S. Ramalingam,J. Carl Barrett,Justin I. Odegaard	2023	4
2	Olaparib for Metastatic Castration-Resistant Prostate Cancerbreakdown → New England Journal of Medicine ·Johann S. de Bono,Joaquı́n Mateo,Karim Fizazi,Fred Saad,Neal D. Shore,Shahneen Sandhu,Kim N.,Oliver Sartor,Neeraj Agarwal,David Olmos,Antoine Thiery-Vuillemin,Przemyslaw Twardowski,Niven Mehra,Carsten Goessl,Jinyu Kang,Joseph E. Burgents,Wenting Wu,Alexander Kohlmann,Carrie A. Adelman,Maha Hussain	2020	1397
3	Programmed Cell Death Ligand 1 Expression in Untreated EGFR Mutated Advanced NSCLC and Response to Osimertinib Versus Comparator in FLAURA Journal of Thoracic Oncology ·Helen Brown,Johan Vansteenkiste,Kazuhiko Nakagawa,Manuel Cobo,Thomas John,Craig Barker,Alexander Kohlmann,Wilda Olivares,Matilde Saggese,Juliann Chmielecki,Aleksandra Markovets,Marietta Scott,Suresh S. Ramalingam	2019	38
4	Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology Critical Reviews in Oncology/Hematology ·Evgenii Shumilov,Johanna Flach,Thomas Pabst,Martin Fiedler,Anne Angelillo‐Scherrer,Lorenz Trümper,Ivan Y. Luu,Alexander Kohlmann,Ulrike Bacher	2018	9
5	Savolitinib versus sunitinib in patients with MET-driven, unresectable and locally advanced or metastatic papillary renal cell carcinoma: SAVOIR, a randomised, phase III trial Annals of Oncology ·Toni K. Choueiri,Regina I. Jakacki,Dana Ghiorghiu,Vincent Haddad,Alexander Kohlmann,Melanie M. Frigault,Lone H. Ottesen	2017	6
6	Selumetinib in combination with docetaxel as second-line treatment for patients with KRAS-mutant advanced NSCLC: Results from the phase III SELECT-1 trial Annals of Oncology ·Pasi A. Jänne,Michel M. van den Heuvel,Fabrice Barlési,Francisco Javier Acién,Julien Mazières,Lucio Crinò,Sergey Orlov,Fiona Blackhall,Jennifer Moriatis Wolf,Pilar Garrido,Artem Poltoratskiy,G Mariani,Dana Ghiorghiu,Elaine Kilgour,Paul D. Smith,Alexander Kohlmann,David Carlile,David Lawrence,Karin Bowen,Johan Vansteenkiste	2016	10
7	Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome Nature Communications ·Vikas Madan,Deepika Kanojia,Jia Li,Ryoko Okamoto,Aiko Sato‐Otsubo,Alexander Kohlmann,Masashi Sanada,Vera Großmann,Janani Sundaresan,Yuichi Shiraishi,Satoru Miyano,Felicitas Thol,Arnold Ganser,Henry Yang,Torsten Haferlach,Seishi Ogawa,H. Phillip Koeffler	2015	173
8	SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML) Blood ·Manja Meggendorfer,Andreas Roller,Torsten Haferlach,Christiane Eder,Frank Dicker,Vera Grossmann,Alexander Kohlmann,Tamara Alpermann,Kenichi Yoshida,Seishi Ogawa,H. Phillip Koeffler,Wolfgang Kern,Claudia Haferlach,Susanne Schnittger	2012	219
9	Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases Haematologica ·Susanne Schnittger,Ulrike Bacher,Tamara Alpermann,Andreas Reiter,Markus Nisch,Frank Dicker,Christiane Eder,Alexander Kohlmann,Vera Großmann,Andreas Kowarsch,Wolfgang Kern,Claudia Haferlach,Joann R. Basabe	2012	21
10	Molecular analysis of RAS-RAF tyrosine-kinase signaling pathway alterations in patients with plasma cell myeloma Blood Cancer Journal ·Vera Großmann,Ulrike Bacher,Valentina Artusi,Alexander Kohlmann,Niroshan Nadarajah,Wolfgang Kern,Susanne Schnittger,Torsten Haferlach,Claudia Haferlach	2012	2
11	Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases Genes Chromosomes and Cancer ·Claudia Haferlach,Ulrike Bacher,Vera Grossmann,Sonja Schindela,Melanie Zenger,Alexander Kohlmann,Wolfgang Kern,Torsten Haferlach,Susanne Schnittger	2012	26
12	Strategy for Robust Detection of Insertions, Deletions, and Point Mutations in CEBPA, a GC-Rich Content Gene, Using 454 Next-Generation Deep-Sequencing Technology Journal of Molecular Diagnostics ·Vera Großmann,Susanne Schnittger,Sonja Schindela,Hans‐Ulrich Klein,Christiane Eder,Martin Dugas,Wolfgang Kern,Torsten Haferlach,Claudia Haferlach,Alexander Kohlmann	2011	30
13	Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia Haematologica ·Vera Grossmann,Wolfgang Kern,I. S. Moshkina,Tamara Alpermann,Yin Zu-xing,Susanne Schnittger,Claudia Haferlach,Torsten Haferlach,Alexander Kohlmann	2011	55
14	Targeted next-generation sequencing detects point mutations, insertions, deletions and balanced chromosomal rearrangements as well as identifies novel leukemia-specific fusion genes in a single procedure Leukemia ·Vera Großmann,Alexander Kohlmann,Hans‐Ulrich Klein,Sonja Schindela,Susanne Schnittger,Frank Dicker,Martin Dugas,Wolfgang Kern,Torsten Haferlach,Claudia Haferlach	2011	35
15	AML with translocation t(8;16)(p11;p13) demonstrates unique cytomorphological, cytogenetic, molecular and prognostic features Leukemia ·Torsten Haferlach,Alexander Kohlmann,Hans‐Ulrich Klein,Christian Rückert,Martin Dugas,P. Michele Williams,Wolfgang Kern,Susanne Schnittger,Ulrike Bacher,H. Löffler,Claudia Haferlach	2009	57
16	Perspectives of gene expression profiling for diagnosis and therapy in haematological malignancies Briefings in Functional Genomics and Proteomics ·Ulrike Bacher,Alexander Kohlmann,Torsten Haferlach	2009	4
17	New insights into MLL gene rearranged acute leukemias using gene expression profiling: shared pathways, lineage commitment, and partner genes Leukemia ·Alexander Kohlmann,Claudia Schoch,Martin Dugas,Susanne Schnittger,W. Hiddemann,Wolfgang Kern,Torsten Haferlach	2005	66
18	Gene Expression Profiling as a Diagnostic Tool in Acute Myeloid Leukemia PubMed ·Wolfgang Kern,Alexander Kohlmann,Susanne Schnittger,Wolfgang Hiddemann,Claudia Schoch,Torsten Haferlach	2004	6
19	Multi-genetic basis for prognostication in acute myeloid leukemia with aberrant and prognostically intermediate karyotypes as determined by gene expression profiling Blood ·Wolfgang Kern,Claudia Schoch,Alexander Kohlmann,Martin Dugas,Susanne Schnittger,W. Hiddemann,Torsten Haferlach	2003	1
20	Molecular characterization of acute leukemias by use of microarray technology Genes Chromosomes and Cancer ·Alexander Kohlmann,Claudia Schoch,Susanne Schnittger,Martin Dugas,Wolfgang Hiddemann,Wolfgang Kern,Torsten Haferlach	2003	107

About Alexander Kohlmann

Alexander Kohlmann is a scholar working on Hematology, Genetics, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 181 papers that have together received 7.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (115 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (34 papers), Cancer Genomics and Diagnostics (34 papers), Chronic Lymphocytic Leukemia Research (27 papers), Chronic Myeloid Leukemia Treatments (27 papers), Gene expression and cancer classification (24 papers), Acute Lymphoblastic Leukemia research (22 papers) and Advanced biosensing and bioanalysis techniques (16 papers). The work is most often cited by research in Hematology (3.6k citations), Genetics (1.8k citations), Cancer Research (1.4k citations), Oncology (1.7k citations) and Molecular Biology (3.8k citations). Alexander Kohlmann has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Torsten Haferlach, Susanne Schnittger, Wolfgang Kern, Claudia Haferlach, Martin Dugas, Claudia Schoch, Vera Grossmann, Frank Dicker, Tamara Alpermann and Christiane Eder. Their work appears in journals such as Blood, Leukemia, Genes Chromosomes and Cancer, Annals of Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact